Clinical Tuberculosis (6th Edition)

Description

Entirely updated and revised, the 6th edition of Clinical Tuberculosis continues to provide the TB physician with a definitive and erudite account of the latest techniques in diagnosis, treatment and control of TB, including an overview of the latest guidelines from the CDC and WHO. With an increased emphasis on the clinical aspects and treatment, this book will be an invaluable resource to the TB practitioner in public health or clinical practice and an ideal reference to laboratory staff.

Key Features

• Completely updated and reorganized
• Includes brand new chapters on radiology and an overview of the latest WHO, ATS/CDC/IDSA, ERS, NICE, CTS and IUATLD guidelines
• Clinically focused to provide up-to-date guidance on diagnosis, treatment and control
• Edited by three renowned experts in the field of tuberculosis

Table of Contents

1. Foreword
2. Preface
3. Editors
4. Contributors
5. BACKGROUND
6. The History of Tuberculosis from Earliest Times to the Development of Drugs
   1. Charlotte A. Roberts and Jane E. Buikstra
7. Epidemiology
   1. Grant Theron, Ted Cohen, and Christopher Dye
8. PATHOLOGY AND IMMUNOLOGY
9. Mycobacterium tuberculosis: The Genetic Organism
   1. William R. Jacobs, Jr.
10. Pathogenesis of Tuberculosis
    1. Divya B. Reddy and Jerrold J. Ellner
11. TRANSMISSION
12. Using Genotyping and Molecular Surveillance to Investigate Tuberculosis Transmission
    1. Sarah Talarico, Laura F. Anderson, and Benjamin J. Silk
13. Tuberculosis Transmission Control
    1. Edward A. Nardell
14. DIAGNOSIS OF ACTIVE DISEASE AND LATENTINFECTION
15. Diagnosis of Active Pulmonary Tuberculosis
    1. J. Lucian Davis
16. Radiology of Mycobacterial Disease
    1. Anne McB. Curtis
17. Diagnosis of Latent TB Infection
    1. Ajit Lalvani, Clementine Fraser, and Manish Pareek
18. DRUGS AND VACCINES FORTUBERCULOSIS
19. Clinical Pharmacology of the Anti-Tuberculosis Drugs
    1. Gerry Davies and Charles Peloquin
20. New Developments in Drug Treatment
    1. Alexander S. Pym, Camus Nimmo, and James Millard
21. BCG and Other Vaccines
    1. Rachel Tanner and Helen McShane
22. CLINICAL ASPECTS AND TREATMENT
23. Pulmonary Tuberculosis
    1. Charles S. Dela Cruz, Barbara Seaworth, and Graham Bothamley
24. Extrapulmonary Tuberculosis
    1. Charles L. Daley
25. Tuberculosis and Human Immunodeficiency Virus Coinfection
    1. Charisse Mandimika and Gerald Friedland
26. Drug-Resistant Tuberculosis
    1. Keertan Dheda, Aliasgar Esmail, Anzaan Dippenaar, Robin Warren, Jennifer Furin, and Christoph Lange
27. The Surgical Management of Tuberculosis and Its Complications
    1. Richard S. Steyn
28. Tuberculosis in Childhood and Pregnancy
    1. Lindsay H. Cameron and Jeffrey R. Starke
29. Treatment of Latent Tuberculosis Infection Including Risk Factors for the Development of Tuberculosis
    1. Martin Dedicoat
30. OFFICIAL STATEMENTS: COMPARISON OF NATIONAL AND INTERNATIONAL RECOMMENDATIONS
31. Treatment Guidelines for Active Drug-Susceptible and Drug-Resistant Pulmonary Tuberculosis, and Latent Tuberculosis Infection
    1. Lynn E. Sosa and Lloyd N. Friedman
32. CONTROL
33. Tuberculosis Epidemic Control: A Comprehensive Strategy to Drive Down Tuberculosis
    1. Salmaan Keshavjee, Tom Nicholson, Aamir J. Khan, Lucica Ditiu, Paul E. Farmer, and Mercedes C. Becerra
34. RELATED ASPECTS
35. Animal Tuberculosis
    1. Catherine Wilson
36. Index

Reviews

This sixth edition encompasses multiple aspects of Mycobacterium tuberculosis infection. Anyone actively involved in controlling tuberculosis should consider this book as a reference. It is suited to healthcare providers in both clinical and public health settings, especially if involved in tuberculosis eradication programs where complex situations arise with certain frequency. The editors and contributing authors are experts in the subject. The organization is logical for any infectious disease book, and the book strikes a good balance between depth and breadth. It is more accessible as a guideline for providers engaged in treating patients with tuberculosis or public health officers involved in eradication efforts.

Carlos E Figueroa Castro, MD(Medical College of Wisconsin)

Editors Biography

Lloyd N. Friedman, M.D., is a Clinical Professor of Pulmonary, Critical Care and Sleep Medicine at the Yale School of Medicine, New Haven, CT. He is Director of Inpatient Quality and Safety for the Department of Internal Medicine. He is a member of the American Thoracic Society, a member of the Society of Critical Care Medicine, a fellow of the American College of Chest Physicians and a member of the International Union Against Tuberculosis and Lung Disease. He is Chairman of the Connecticut Tuberculosis Elimination Advisory Committee.

Martin Dedicoat PhD, FRCP, BSc, DTM&H is a Consultant physician in infectious diseases at the University Hospitals Birmingham. He is currently clinical lead for tuberculosis for Birmingham and Solihull, UK. His main research interests center around tuberculosis transmission in urban settings. Dr Dedicoat is a member of the British Thoracic Society drug resistant tuberculosis management group advising on management of complex tuberculosis patients across the UK. He also sits on the National Tuberculosis board for England.

Dr. Peter D. O. Davies graduated in 1966 from Marlborough College, Wilts, UK and obtained his BM, BCh and MA from University College, Oxford, UK in 1971 and St. Thomas’s Hospital in London in 1973. He gained a DM from oxford in 1984. He was a Consultant General and Respiratory Physician at Aintree University Hospital from 1988 to 2011 and at Liverpool Heart Chest Hospital from 1988 to 2015. He is or has been a member of the British Medical Association, the British Thoracic Society, the European Respiratory Society, the Royal College of Physicians of London (Fellow), the Royal Society of Medicine, the American Thoracic Society, the North Western Society of Respiratory Physicians where he served as President in 2007, the International Union Against Tuberculosis and Lung Disease where he was Chair of the Tuberculosis Section, President of the European section, and Editor in Chief of the International Journal of Tuberculosis and Lung Disease, and a member of NICE where he was chair of the Tuberculosis Section. He co-founded the UK Based TB charity in 1998. Dr. Davies is an expert in tuberculosis and edited the inaugural edition of the textbook, Clinical Tuberculosis in 1994 and has continued as editor for the subsequent 5 editions.